← Evidence map

ArticleCrohn's & colitis 3602021

Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience.

Guilherme Piovezani Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36776673